Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Influences on antidepressant prescribing trends in the UK: 1995-2011.

Mars B, Heron J, Kessler D, Davies NM, Martin RM, Thomas KH, Gunnell D.

Soc Psychiatry Psychiatr Epidemiol. 2017 Feb;52(2):193-200. doi: 10.1007/s00127-016-1306-4. Epub 2016 Nov 24.

2.

Long-term trend in pediatric antidepressant use, 1983-2007: a population-based study.

Meng X, D'Arcy C, Tempier R.

Can J Psychiatry. 2014 Feb;59(2):89-97. Review.

3.

Safety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder.

Findling RL, Groark J, Chiles D, Ramaker S, Yang L, Tourian KA.

J Child Adolesc Psychopharmacol. 2014 May;24(4):201-9. doi: 10.1089/cap.2012.0126. Epub 2014 Mar 10.

4.

Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN).

Wijlaars LP, Nazareth I, Petersen I.

PLoS One. 2012;7(3):e33181. doi: 10.1371/journal.pone.0033181. Epub 2012 Mar 13.

5.

Unlicensed use of metformin in children and adolescents in the UK.

Hsia Y, Dawoud D, Sutcliffe AG, Viner RM, Kinra S, Wong IC.

Br J Clin Pharmacol. 2012 Jan;73(1):135-9. doi: 10.1111/j.1365-2125.2011.04063.x.

6.

Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.

Laje G, Allen AS, Akula N, Manji H, John Rush A, McMahon FJ.

Pharmacogenet Genomics. 2009 Sep;19(9):666-74. doi: 10.1097/FPC.0b013e32832e4bcd.

7.

An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database.

Hsia Y, Neubert AC, Rani F, Viner RM, Hindmarsh PC, Wong IC.

Br J Clin Pharmacol. 2009 Feb;67(2):242-9. doi: 10.1111/j.1365-2125.2008.03347.x.

8.

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

Collin SM, Martin RM, Metcalfe C, Gunnell D, Albertsen PC, Neal D, Hamdy F, Stephens P, Lane JA, Moore R, Donovan J.

Lancet Oncol. 2008 May;9(5):445-52. doi: 10.1016/S1470-2045(08)70104-9. Epub 2008 Apr 16.

9.

Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J.

CMAJ. 2008 Apr 8;178(8):1005-11. doi: 10.1503/cmaj.071265. Erratum in: CMAJ. 2008 May 20;178(11):1466.

10.

The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study.

Wheeler BW, Gunnell D, Metcalfe C, Stephens P, Martin RM.

BMJ. 2008 Mar 8;336(7643):542-5. doi: 10.1136/bmj.39462.375613.BE. Epub 2008 Feb 14.

Supplemental Content

Support Center